Does vitamin D really help with chronic pain and jaw discomfort?

Patients often ask whether vitamins or supplements can help their jaw pain. The honest answer is that for most supplements, the evidence is weak. Vitamin D is the notable exception — there is real, replicable evidence that low vitamin D is linked to chronic musculoskeletal pain, and that correcting a deficiency can make a meaningful difference. This article looks at what the evidence actually says.

How common is deficiency in the UK?

Vitamin D deficiency is extraordinarily common in the UK. The latest National Diet and Nutrition Survey found that roughly 20% of UK adults have vitamin D levels below the deficiency threshold (25 nmol/L) at the end of winter, with up to 40% in some ethnic groups (Public Health England, 2020). The biological reason is simple: UK latitude (above 50°N) means UVB radiation is insufficient to drive skin synthesis of vitamin D from October to April. Dietary sources (oily fish, eggs, fortified foods) cover only a fraction of the requirement.

What does vitamin D do, in pain terms?

Vitamin D is technically a hormone, not a vitamin. It has receptors on cells throughout the body — including in skeletal muscle, the central nervous system, and immune cells. Three pain-related functions matter:

• Muscle function. Severe deficiency causes proximal muscle weakness, fatigue and pain — a syndrome sometimes called "vitamin D myopathy". Even sub-clinical deficiency reduces muscle performance (Holick, 2017).
• Inflammatory modulation. Vitamin D modulates pro-inflammatory cytokines (TNF-α, IL-6) which are involved in chronic pain pathways.
• Nervous system signalling. Vitamin D receptors are widely expressed in the spinal cord and brain, where they appear to influence pain processing thresholds.

The evidence — what actually replicates

The most rigorous data come from systematic reviews and meta-analyses of randomised trials of vitamin D supplementation in chronic pain populations:

• A 2017 meta-analysis of 19 RCTs (3,436 participants) concluded that vitamin D supplementation produced a small but statistically significant reduction in chronic widespread pain and fibromyalgia symptoms, with the largest effects in patients who were genuinely deficient at baseline (Yong et al., 2017).
• A 2018 systematic review specific to musculoskeletal pain found supplementation reduced pain scores by an average of 0.6 points on a 10-point scale — modest, but real, and at very low cost (Wu et al., 2018).
• For headache, the picture is mixed. A 2019 meta-analysis found a modest reduction in migraine frequency with supplementation, but only in deficient patients (Hu et al., 2019).

The signal is clearest when you separate deficient patients from replete patients. Supplementing someone who already has adequate vitamin D produces no detectable benefit. Supplementing someone whose level is below 50 nmol/L produces measurable improvements in pain and function within 8–12 weeks.

What about vitamin D and TMD specifically?

The TMD-specific evidence base is smaller but pointing in the same direction. A 2019 case-control study compared 100 TMD patients with 100 matched controls and found TMD patients were 2.4 times more likely to have vitamin D deficiency (Demir et al., 2019). A 2021 pilot RCT showed supplementation in deficient TMD patients improved pain and mouth opening at 8 weeks compared with placebo (Karaman et al., 2021). The evidence is preliminary, but consistent.

How to know whether you need it

The only reliable way is a blood test — 25-hydroxyvitamin D (25(OH)D). This can be done via your GP, or via a private home-test kit for around £30. Interpretation:

• <25 nmol/L — deficient. Supplementation strongly indicated.
• 25–50 nmol/L — insufficient. Supplementation usually appropriate, particularly in winter.
• 50–75 nmol/L — adequate.
• 75–125 nmol/L — optimal for most outcomes.
• >125 nmol/L — high. Probably no additional benefit.

Practical dosing

UK Public Health England guidance recommends 10 µg (400 IU) per day from October to April for the general adult population, with year-round supplementation in higher-risk groups including those with darker skin, indoor lifestyles, or covered clothing (PHE, 2020). For documented deficiency, 1,000–2,000 IU per day is commonly prescribed for 8–12 weeks, followed by maintenance at 800–1,000 IU. Doses above 4,000 IU per day are not necessary outside of medically supervised replacement and may risk hypercalcaemia in some patients.

Vitamin D3 (cholecalciferol) is preferable to D2 (ergocalciferol) — D3 raises serum 25(OH)D more efficiently. Taking it with a meal containing fat improves absorption.

What vitamin D will NOT do

Correcting a vitamin D deficiency is not a cure for TMD, headaches or chronic pain. It is one piece of a complete picture. If a patient is deficient, replacing it removes one identifiable contributor to muscle dysfunction and chronic-pain processing — but the physiotherapy, behavioural and lifestyle pillars still need to be in place.

The takeaway

Vitamin D is one of the few supplements with genuine, replicable evidence in chronic musculoskeletal pain. The catch is that it only helps if you are actually deficient — and in the UK, 1 in 5 adults are. A simple blood test resolves the question. If you are deficient, 8–12 weeks of supplementation often produces a small but real improvement in pain, fatigue and mood. If you are replete, save your money. As with any clinical decision, do this in conversation with your GP, particularly if you have a history of kidney disease, hypercalcaemia, or are taking medications that affect calcium metabolism.